These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403 [TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors and anticonvulsants. Brooks J; Daily J; Schwamm L AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776 [TBL] [Abstract][Full Text] [Related]
8. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes. Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958 [TBL] [Abstract][Full Text] [Related]
9. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro. Eagling VA; Wiltshire H; Whitcombe IW; Back DJ Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416 [TBL] [Abstract][Full Text] [Related]
14. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Fitzsimmons ME; Collins JM Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions. Decker CJ; Laitinen LM; Bridson GW; Raybuck SA; Tung RD; Chaturvedi PR J Pharm Sci; 1998 Jul; 87(7):803-7. PubMed ID: 9649346 [TBL] [Abstract][Full Text] [Related]
16. [Drug interactions with antiretroviral agents]. Furlan V; Taburet AM Therapie; 2001; 56(3):267-71. PubMed ID: 11475806 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro. Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896 [TBL] [Abstract][Full Text] [Related]